21
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Preparation of Pancreatic Cancer-Associated Mucin Expressing CA19–9, CA50, Span-1, Sialyl SSEA-1, and Dupan-2

, , , , &
Pages 981-992 | Received 25 Feb 1991, Accepted 18 Apr 1991, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

G. L. Shue, S. Kawa, M. Kato, H. Oguchi, T. Kobayashi, T. Koiwai, M. Tokoo, S. Furuta, M. Kanai & T. Homma. (1993) Expression of Glycoconjugates in Pancreatic, Gastric, and Colonic Tissue by Bauhinia purpurea, Vicia villosa, and Peanut Lectins. Scandinavian Journal of Gastroenterology 28:7, pages 599-604.
Read now
S. Kawa, M. Kato, H. Oguchi, G. L. Hsue, T. Kobayashi, T. Koiwai, M. Tokoo, S. Furuta, T. Ichikawa & M. Kanai. (1992) Clinical Evaluation of Pancreatic Cancer-Associated Mucin Expressing CA19-9, CA50, Span-1, Sialyl-SSEA-l, and Dupan-2. Scandinavian Journal of Gastroenterology 27:8, pages 635-643.
Read now
S. Kawa, M. Kato, H. Oguchi, T. Kobayashi, G. L. Hsue, T. Koiwai, Y. Aoki, S. Furuta & M. Kanai. (1991) Preparation and Partial Characterization of a Pancreatic Cancer-Associated Glycoprotein Expressing CA50. Scandinavian Journal of Gastroenterology 26:12, pages 1307-1318.
Read now

Articles from other publishers (14)

Kosuke Shimizu. (2016) Challenge to the development of diagnostic and therapeutic drugs using liposomal drug delivery systems:8<sup>th</sup> Young Scientist Award, Japan Society of DDS. Drug Delivery System 31:4, pages 352-360.
Crossref
Keisuke Ikemoto, Kosuke Shimizu, Kento Ohashi, Yoshihito Takeuchi, Motohiro Shimizu & Naoto Oku. (2015) Bauhinia purprea agglutinin ‐modified liposomes for human prostate cancer treatment . Cancer Science 107:1, pages 53-59.
Crossref
Ignacio Garrido-Laguna, María de la Luz Amador, Juan Ruiz & Hernán Cortés-Funes. (2009) Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer. Clinical and Translational Oncology 11:3, pages 183-185.
Crossref
Janet M.D. Plate. (2007) Current Immunotherapeutic Strategies in Pancreatic Cancer. Surgical Oncology Clinics of North America 16:4, pages 919-943.
Crossref
Ajit Varki. (2007) Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110:6, pages 1723-1729.
Crossref
Mark Wahrenbrock, Lubor Borsig, Dzung Le, Nissi Varki & Ajit Varki. (2003) Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. Journal of Clinical Investigation 112:6, pages 853-862.
Crossref
Mark Wahrenbrock, Lubor Borsig, Dzung Le, Nissi Varki & Ajit Varki. (2003) Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. Journal of Clinical Investigation 112:6, pages 853-862.
Crossref
Asma Farhat Sherwani, Sameena Mohmood, Fauzia Khan, Rizwan Hasan Khan & Md. Asim Azfer. (2003) Characterization of lectins and their specificity in carcinomas—An appraisal. Indian Journal of Clinical Biochemistry 18:2, pages 169-180.
Crossref
Tatsuo Shimura, Souichi Tsutsumi, Yasuo Hosouchi, Takahiro Kojima, Youichi Kon, Mayumi Yonezu & Hiroyuki Kuwano. (2001) Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer. Human Immunology 62:6, pages 615-619.
Crossref
Jonathan M. Rhodes. (1999) Usefulness of novel tumour markers. Annals of Oncology 10, pages S118-S121.
Crossref
T. Ming Chu. (1997) Molecular diagnosis of pancreas carcinoma. Journal of Clinical Laboratory Analysis 11:4, pages 225-231.
Crossref
S. Kannan & M. Krishnan Nair. 1996. Glycosciences. Glycosciences 563 583 .
M. Plebani, D. Basso, M.P. Panozzo, P. Fogar, G. Del Favero & R. Naccarato. (2018) Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art. The International Journal of Biological Markers 10:4, pages 189-199.
Crossref
Maureen A. Chung & Helena R. Chang. (2006) Clinical use of tumor markers in pancreatic carcinoma. Seminars in Surgical Oncology 11:2, pages 103-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.